期刊
BIOCHEMISTRY MOSCOW-SUPPLEMENT SERIES B-BIOMEDICAL CHEMISTRY
卷 13, 期 1, 页码 26-35出版社
MAIK NAUKA-INTERPERIODICA
DOI: 10.1134/S1990750819010074
关键词
platelet; CLEC-2 receptor; tyrosine kinases; lymphangiogenesis; metastasis; podoplanin
资金
- Russian Foundation for Basic Research [17-54-04009, 17-00-00138]
- Russian Federation for young scientists [MD-229.2017.4]
Platelet activating lectin-like receptor type C-2 (CLEC-2) has been identified on the platelet surface about a decade ago. The only known endogenous CLEC-2 agonist is podoplanin, a transmembrane protein expressed by lymphatic endothelial cells, lymph node fibroblastic reticular cells, kidney podocytes, and by cells of certain tumors. CLEC-2 and podoplanin are involved in metastases, sepsis, development of deep-vein thrombosis. The CLEC-2 signaling cascade includes tyrosine kinases (Syk, SFK, Btk) as well as LAT adapter, and phospholipase C2, which induces calcium signalling. CLEC-2, podoplanin and proteins, participating in the CLEC-2 signalling cascade, are considered as perspective targets for antithrombotic therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据